Cervical Cytology Instruments

Flexibility and efficiency for actionable clinical results

Discover BD cytology testing instruments

Flexible solutions for any volume and every paradigm

Cytology primary Cytology Sample Preparation
HPV primary Cytology Slide Preparation and Staining
Co-testing Cytology Imaging and Screening

Cytology Sample Preparation

BD’s cytology sample preparation methodology utilises a proprietary cell enrichment processing to remove obscuring elements from the sample, both improving cervical disease detection and reducing the incidence of unsatisfactory results.

sample Low-mid volume testing
sample Mid-high volume testing

Cytology Slide Preparation and Staining

Fully automated slide processing from sample transfer to staining. The BD Totalys™ SlidePrep offers discreet individual slide staining with reduced risk of contamination whilst ensuring sample chain of custody.

sample All testing volumes

Cytology Imaging and Screening

The BD FocalPoint™ GS Imaging System improves cervical cancer detection and screening efficiency by ranking slides and prioritizing the review of locations of interest on both BD SurePath™ Liquid-based Pap Test and conventional preparations.

sample All testing volumes

Meet the BD PrepMate™ automated accessory

Precise specimen transfer directly from BD SurePath™ Collection Vials for BD's proprietary cell enrichment process


Providing simple and fast automation

  • Automated process handling 1 to 12 samples per cycle1
  • Predictably mixes, aspirates and dispenses a defined volume of specimen
  • Eliminates manual cap removal, reducing the risk of contamination
  • Fast sample processing, taking less than 5 minutes to run 12 samples
  • Simple user interface and small footprint

1. BD PrepMate™ automated accessory Operator’s Manual [500005571]. Franklin Lakes, NJ: Becton, Dickinson and Company; 2020.
2. Nance KV. Evolution of Pap testing at a community hospital: a ten year experience. Diagn Cytopathol. 2007 Mar;35(3):148-53.
3. Sweeney BJ, Haq Z, Happel JF, Weinstein B, Schneider D. Comparison of the effectiveness of two liquid-based Papanicolaou systems in the handling of adverse limiting factors, such as excessive blood. Cancer. 2006 Feb 25;108(1):27-31.
4. Moriarty A, Clayton A, Zaleski S et al. Unsatisfactory Reporting Rates: 2006 Practices of Participants in the College of American Pathologists Interlaboratory Comparison Program in Gynecologic Cytology. Arch Pathol Lab Med. 2009;133(12):1912–1916

Download brochure

Meet the BD Totalys™ MultiProcessor

Designed to meet the needs of evolving cervical cancer screening


  • Automates the unique BD cellular enrichment process for BD SurePath™ Liquid-based Pap test
  • Optional, customizable aliquots supports ancillary molecular testing, including the BD Onclarity™ HPV Assay
  • Full chain of custody from collection vial to sample outputs
  • Intuitive touch-screen interface puts the entire process at your fingertips

Download brochure

Technical Specifications




Cervical cancer


Fully automated

Integrated data management

Liquid-based cytology

Aliquot option

Intuitive interface

Electrical specifications

Voltage 100-240 VAC ± 10%
Current 10-6 A
Input line frequency 47-63 Hz

Operating conditions

Temperature 18°C – 30°C / 64.4°F – 86°F
Humidity 20% to 80%, non-condensing
Locations Level surface; no direct heat
Altitude Up to 2000m (6562ft)
Light conditions From dark to 15000 lux; no direct light

Specimen handling

Specimen collection type BD SurePath™ Collection Vial
Sample volume 6mL or 8mL aliquot drawn for cytology testing
Customizable molecular aliquots from 0.25 mL – 1.5 mL*/td>
On-board sample capacity Up to 96 patient samples (6 trays x 16 samples)
Positive sample identification 2D barcodes on all patient vials and instrument consumables ensure chain of custody

*One transfer per sample only

Meet the BD Totalys™ SlidePrep

Full automation from preparation to staining*


  • Processes BD SurePath™ Liquid-based Pap test and Non-Gynaecological samples
  • Fully integrates with the BD Totalys™ MultiProcessor to maintain continuous chain-of-custody
  • Consistent results with staining in individual chambers using fresh reagents for every sample
  • Accurate reagent pipetting and precise timing for each sample reduces process variability

* When used with the BD Totalys™ MultiProcessor

Download brochure

Meet the BD FocalPoint™ GS Imaging System

Taking Pap testing to a different level


  • Statistically significant increases in disease detection over the manual screening method1
  • Directed QC technology™ flags up to 15% of highest ranked cases diagnosed as negative for additional review to assist in the reduction of false negative diagnoses1
  • ‘No Further Review’ functionality enables triaging of up to 25% of lower ranked slides without the requirement for secondary screening
  • Compared to manual screening, the BD FocalPoint™ GS Imaging System was associated with a 42% overall decrease in ASC / SIL ratio1, leading to more accurate diagnosis.

ACS, atypical squamous cells; HSIL, high-grade squamous intraepithelial lesions; LSIL, low-grade squamous intraepithelial lesions.

1. BD FocalPoint™ GS Imaging System Product Insert. 2. Bowditch R.C, Clarke J.M, Baird P.J, Greenberg M.L. Diagn Cytopathol. 2012;40(12):1093-1099.

Download brochure

Contact us to discuss how we can support your cervical cancer screening needs.

Contact us

Contact Us